SCHEMBL26325420

SCHEMBL26325420

c1ccc2cc(-c3ccc(-c4ccc(-c5cc6sc(-c7ccc(-c8ccc(-c9cc%10cccccc-%10c9)cc8)cc7)cc6s5)cc4)cc3)cc-2cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 2/20 0.47
HSD17B2 P37059 2/20 0.47
ESR1 P03372 2/20 0.47
ESR2 Q92731 1/20 0.47
APP P05067 2/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
LOXL2 Q9Y4K0 1/20 0.42
ABL1 P00519 1/20 0.42
ABCB1 P08183 1/20 0.42
BCR P11274 1/20 0.42
PIK3CA P42336 1/20 0.42
PI4KA P42356 1/20 0.42
PI4KB Q9UBF8 1/20 0.42
MAOA P21397 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
KMO O15229 1/20 0.41
ALOX5 P09917 1/20 0.40
ACMSD Q8TDX5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1105093 0.93 ESR1 (0.52) HSD17B1HSD17B2ESR1ESR2APP
SCHEMBL12562762 0.93 ESR1 (0.52) HSD17B1HSD17B2ESR1ESR2APP
SCHEMBL10100932 0.89 ESR1 (0.55) HSD17B1HSD17B2ESR1ESR2APP
SCHEMBL23555830 0.83 ESR1 (0.44) HSD17B1HSD17B2ESR1ESR2APP
SCHEMBL23555429 0.82 ESR1 (0.43) HSD17B1HSD17B2ESR1ESR2APP
SCHEMBL20804567 0.79 HSD17B1 (0.45) HSD17B1HSD17B2ESR1ESR2MEN1
SCHEMBL20804592 0.79 ESR1 (0.58) HSD17B1HSD17B2ESR1ESR2APP
SCHEMBL20662909 0.78 RAB9A (0.45) HSD17B1HSD17B2ESR1ESR2APP
SCHEMBL20662908 0.78 RAB9A (0.45) HSD17B1HSD17B2ESR1ESR2APP
SCHEMBL20804575 0.78 ESR1 (0.61) HSD17B1HSD17B2ESR1ESR2APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11770974-B2 P active materials for organic photoelectric conversion layers in organic photodiodes SONY CORPORATION (JP) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11770974-B2 P active materials for organic photoelectric conversion layers in organic photodiodes JUP, L1CAM, EPCAM HSD17B1 4778/4885HSD17B2 4604/4885ESR1 560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.